radiographic techniques, al, 22 On the basis of these observations, the radiolabeled somatostatin ana- 111 1 logue [ In-DTPA-D-Phe ]-octreotide has been applied clinically to visualize NHLs in vivo, with no toxicity. 2~- 24 We describe the results of a prospective study comparing SS-R scintigraphy with conventional staging methods in 14 patients with CTCL and CBCL.
PATIENTS AND METHODS
Between 1991 and 1994, 14 consecutive patients with histologically proven CTCL (n = 11) and CBCL (n = 3) underwent staging evaluation. The stage of the disease was established by physical examination; whole body mapping of lesions; chest radiography; computed tomography (CT) of chest, abdomen, and pelvis; bone marrow aspiration and biopsy; and analysis of blood smears. CT scanning was performed with contiguous 10 mm axial sections after oral and intravenous administration of contrast material. Lymph node excisions were performed in patients with palpable lymph nodes.
Mycosis fungoides was staged according to a staging classification of Fuks, 7, 12 , and the technique of scintigraphy with the gamma camera, as well as with single photon emission computed tomography (SPECT) have recently been described. 23,25 Planar total body scintigraphy was performed 24 hours after injection with a large-field-of-view gamma camera (Counterbalance 3700 and ROTA 1I; Siemens Gammasonics, Erlangen, Germany) equipped with a medium-energy collimator. Repeat scintigrams were performed 48 hours after injection when accumulation of radioactivity in the abdomen was observed on the 24-hour scintigrams. In all patients SPECT images of the upper abdomen were made. In normal persons a physiologic accumulation of radioactivity may be seen in the pituitary and thyroid glands, liver, spleen, kidneys, urinary bladder, and occasionally in the gallbladder. The presence of intestinal radioactivity (mainly in the colon at 24 hours) is caused by some hepatobiliary clearance of [UiIn-DTPA-D-Phel]-octreotide and can be reduced by the use of laxatives. 25,26 The scans were evaluated by two investigators (E. P. K. and H. Y.
O.) who did not know the identity of the patients or the results of the conventional staging procedures. Finally the results of SS-R scintigraphy and conventional diagnostic tests were compared by the study coordinator (P. J. v.d.A.). In case of discrepancies additional radiodiagnostic investigations were scheduled, and if practical and possible, histologic verification was attempted. All patients were observed during and after treatment. In three patients SS-R scintigraphy was repeated during followup.
RESULTS
The clinical characteristics of the 14 patients with CTCL (n = 11) and CBCL (n = 3) in whom SS-R scintigraphy was performed are given in Table I . Ten of 14 patients had been treated for long periods with topical corticosteroids. phy and the conventional staging methods are summarized in Table I . Skin evaluation CTCL was limited to the skin in 6 of 11 patients. In five of these six patients (i.e., two patients with pleomorphic CTCL [patients 1 and 2] and three patients with mycosis fungoides [patients 5, 6, and 11]), SS-R scintigraphy was negative. The skin lesions in these patients were macules or plaques. Patient 3 initially had limited plaques of 0.5 to 10 cm diameter on multiple sites of the skin. Only one of these lesions was visualized on SS-R scintigraphy.
Five of 11 patients had CTCL in a more advanced stage. In only one of these patients were the skin lesions shown by SS-R scintigraphy. This patient (No. 9) had multiple, sharply marginated, erythematous minors on the skin of the face and back (Fig. 1) .
Lymph node evaluation
The results of physical examination, CT scanning, and SS-R scintigraphy in relation to lymph node histology are summarized in Table lI . In six patients, diseased lymph nodes of 1.5 to 3 cm in diameter were palpable at physical examination. Five of these patients had generalized lymphadenopathy. These enlarged lymph nodes were all apparent on CT scan. In three patients SS-R scintigraphy was negative in the lymph node areas (patients 3, 7, and 10). Lymph node excisional biopsy specimens in these three patients showed dermatopathic lymphadenopathy. SS-R scintigraphy was positive in the lymph node areas in the other three patients (patients 4, 8, and 9; Fig. 2 ). The lymph node excisional biopsy specimens in these three patients confirmed the involvement of malignant lymphoma. The sensitivity and specificity of the CT scan for malignant lymph node infiltration were 100% and 67%, respectively. The sensitivity and specificity of SS-R scintigraphy for malignant lymph node infiltration were 100% and 100%, respectively.
In the 14 patients no lymphadenopathy in the thorax or abdomen was seen on CT scans of chest, abdomen, and pelvis or by SS-R scintigraphy.
Organ evaluation Dissemination of CTCL to visceral organs or bone marrow was seen in three patients. Patient 7 had a seronegative arthropathy affecting the hands and wrists. SS-R scintigraphy was positive in multiple joints (hands, wrists, elbows, knees, and ankles). A synovial biopsy specimen showed an infiltrate of lymphocytes (exclusively T lymphocytes) and plasma cells in a reactive pattern. T-cell receptor gene rearrangement analysis was performed on skin and synovial specimens, and identical clonal T-cell populations were detected in both (data not shown). Bone marrow infdtration with S6zary cells (15%) was seen in patient 8 but was not apparent on SS-R scintigraphy. CT scanning demonstrated a large adrenal mass (5 to 7 cm) in patient 9. Cytologic examination of a needle aspiration specimen of the adrenal mass confirmed infiltration with CTCL. SS-R scintigraphy was negative in this area.
SS-R scintigraphy during follow-up
In three patients with pleomorphic CTCL, SS-R scintigraphy was repeated during follow-up. Patient 1, with initially negative SS-R scanning, was treated with PUVA therapy. Sixteen months later progressive skin disease had developed as well as lymph node and bone marrow infiltration with CTCL. SS-R scintigraphy was positive in the peripheral lymph node areas, but remained negative in the skin and bone marrow. In patient 2 a complete remission was reached after CHOP chemotherapy. Eleven months later the skin disease recurred (ulcers and plaques). SS-R scintigraphy was again entirely negative. The skin disease in patient 3, originally showing positivity on SS-R scintigraphy, recurred (tumors at multiple sites) 8 months after PUVA therapy and local radiotherapy. On SS-R scintigraphy some skin lesions were positive and some were negative. The patient did not respond to different types of chemotherapy and local radiotherapy. SS-R scintigraphy performed a third time revealed all active skin lesions (tumors).
Patients with CBCL
SS-R scintigraphy was positive in two of three patients with CBCL (Table I ). The skin lesions were visualized by SS-R scintigraphy in two patients. In patient 12, SS-R scintigraphy also revealed a previously unsuspected localization in the mediastinum (Fig. 3, A) . On roentgenography and CT of the thorax (Fig. 3, B ) no abnormalities were seen. However, this patient had radiologic evidence of mediastinal lymphoma 6 months later. Mediastinal lymphoma involvement with pericardial infiltration was confirmed at autopsy. In patient 13 the accumulation of radioactivity in the neck corresponded to a clinically evident skin nodule (2 cm) in the neck. SS-R scintigraphy was entirely negative in the third patient.
Side effects were not noted in any of the patients after the administration of [lllIn-DTPA-D-Phel]-octreotide for SS-R scintigraphy.
DISCUSSION
The prognosis and treatment of patients with CTCL depend on accurate staging. The staging system for CTCL considers the extent of skin involvement, presence of lymph node or visceral disease, and detection of abnormal cells in the peripheral blood. In autopsy series, more than 70% of patients with CTCL have extracutaneous lesions that may involve nearly any organ. 6' 27, 28 Despite the high incidence of extracutaneous CTCL found at autopsy, clinically overt extracutaneous disease, other than that involving peripheral lymph nodes and blood, is uncommon.
In the present study, we employed SS-R scintigraphy in i I patients with histologically proven CTCL and three patients with CBCL. Among these, eight showed a positive SS-R scan. SS-R-positive localizations were apparent at different sites of active disease in the skin and in extracutaneous disease.
Extracutaneous disease in CTCL is frequently found in lymph nodes. Histologic interpretation of lymph nodes in CTCL is sometimes difficult. Unlike the nodes in B-cell lymphomas, most often the nodal architecture is preserved and lymph nodes are rarely totally replaced by malignant T cells. Furthermore, patients with CTCL frequently have benign reactive lymphadenopathy or dermatopathic lymphadenopathy. In dermatopathic lymphadenopathy the paracortical T-cell zones may contain focal accumulations of atypical convoluted T lymphocytes. Southern blot analysis of the T-cell receptor gene has provided evidence of CTCL infiltration in dermatopathic lymph nodes. 29 '30 Patients with malignant lymph nodes tend to have a shorter survival than patients with dermatopathic lymphadenopathy. 9,31 If malignant lymph node infiltration is apparent, patients are usually treated with systemic chemotherapy. This is in contrast to patients with dermatopathic lymphadenopathy to whom chemotherapy is less commonly given. Therefore it is common practice to perform lymph node excisions in patients with CTCL and peripheral enlarged lymph nodes. In our study seven patients initially had or later developed enlarged palpable axillary or inguinal lymph nodes. SS-R scintigraphy was positive in all four of these seven patients with malignant lymph node infiltration. All infiltrated lymph nodes were visualized by SS-R scintigraphy. The lymph node areas were negative on SS-R scintigraphy in the three patients with dermatopathic lymphadenopathy. CT does not allow differentiation between enlarged peripheral lymph nodes with histologic evidence of CTCL and nodes demonstrating dermatopathic lymphadenopathy. Although our series of patients is small, the results would suggest that in contrast to other imaging modafities SS-R scintigraphy may differentiate between malignant lymph node infiltration and dermatopathic lymphadenopathy in patients with CTCL. In patients with enlarged lymph nodes, a surgical lymph node excision might perhaps be avoided on the basis of SS-R scintigraphy results. Another possible advantage of SS-R scintigraphy is that the whole body is imaged, so that localizations not under clinical suspicion can be evaluated. In two patients, previously unsuspected lymphoma localizations were revealed by SS-R scintigraphy, that is, in the mediastinum and multiple joints. Although in patient 7 only reactive T lymphocytes were seen in the synovial specimen, clonality of these T lymphocytes was demonstrated by T-cell receptor gene rearrangement analysis. By analogy with the demonstration of clonal T-cell lymphocytic infiltration in dermatopathic lymphadenopathy, 29, 30 the presence of clonal T lymphocytes alone in the synovia, although not sufficient for the diagnosis of malignant infdtration with CTCL, is highly suggestive of the (pre)malignant character of the infiltrate.
On the other hand, SS-R scintigraphy failed to detect an adrenal mass and bone marrow infdtration. The adrenal mass may not have been detected by SS-R scintigraphy because of the physiologic uptake of the radioligand in the kidneys. This might have interfered with the detection of adrenal involvement, despite the use of SPECT. The reason that bone marrow infiltration was not revealed by SS-R scintigraphy is unclear. A locally low density of receptors and unknown local factors may be involved.
At first sight, SS-R scintigraphy appears of minor value in the confirmation of early skin disease in CTCL. The skin lesions were visualized in only two patients. In both patients the skin disease was in the tumor stage. Skin tumors usually develop at later stages. Only one of several plaques was detected by SS-R scintigraphy in patient 3. This skin lesion was the presenting lesion several years before mycosis fungoides was diagnosed. In the other patients no accumulation of radioactivity was seen in the plaques. We can only speculate as to the reason SS-R scintigraphy failed to visualize these thin lesions. One explanation might be that most of the patients had been treated for long periods with topical corticosteroids. Except for patient 3 in whom only one of several lesions was visualized by SS-R scintigraphy, none of the three other patients in whom the skin lesions were visualized had been treated with topical and CTCL. SS-R scintigraphy was not performed before or after treatment. It is tempting to postulate that patients who have tumors that are shown by SS-R scintigraphy will be most likely to respond to therapy with somatostatin or to radiotherapy with a somatostatin analogue coupled to a [3-emitting radionuclide.
SS-R scintigraphy appears to provide an independent approach to the evaluation of dissemination of CTCL and CBCL. Although further studies are necessary in a larger group of patients before definite conclusions can be made, our results suggest that SS-R scintigraphy may be able to distinguish dermatopathic lymphadenopathy from marlgnant lymph node infiltration in certain patients with CTCL and be useful in a complete staging work-up of patients with cutaneous malignant lymphomas.
